Dental abnormalities in children treated for acute lymphoblastic leukemia

被引:71
|
作者
Kaste, SC
Hopkins, KP
Jones, D
Crom, D
Greenwald, CA
Santana, VM
机构
[1] ST JUDE CHILDRENS RES HOSP, DEPT SURG, MEMPHIS, TN 38101 USA
[2] ST JUDE CHILDRENS RES HOSP, DEPT BIOSTAT, MEMPHIS, TN 38101 USA
[3] ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, MEMPHIS, TN 38101 USA
[4] ST JUDE CHILDRENS RES HOSP, DEPT RADIAT ONCOL, MEMPHIS, TN 38101 USA
[5] UNIV TENNESSEE, COLL MED, DEPT RADIOL, MEMPHIS, TN USA
[6] UNIV TENNESSEE, COLL MED, DEPT PEDIAT DENT, MEMPHIS, TN USA
[7] UNIV TENNESSEE, COLL MED, DEPT RADIAT THERAPY, MEMPHIS, TN USA
[8] UNIV TENNESSEE, COLL MED, DEPT PEDIAT, MEMPHIS, TN USA
关键词
acute lymphoblastic leukemia; taurodontia; microdontia; root stunting; late effects;
D O I
10.1038/sj.leu.2400670
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The purpose of this study was to define the therapy-associated dental abnormalities in survivors of acute lymphoblastic leukemia (ALL). We reviewed the clinical records and panoramic radiographs of 423 survivors of ALL who were treated on one of four consecutive protocols (1975-1991). Dental abnormalities included root stunting, microdontia, hypodontia, taurodontia (enlarged pulp chambers), and over-retention of primary teeth. The frequency of these factors was determined in relation to age at initiation of treatment (less than or equal to 8 years vs >8 years), addition of cranial irradiation, and chemotherapeutic protocol. A total of 423 patients met the study criteria. The abnormalities comprised root stunting in 24.4% (n = 103), microdontia in 18.9% (n = 80), hypodontia in 8.5% (n = 36), taurodontia in 5.9% (n = 25), and over-retention of primary dentition in 4.0% (n = 17). Patients who were less than or equal to 8 years old at diagnosis or who received cranial irradiation therapy developed more dental abnormalities than did those >8 years and those who did not receive cranial irradiation (42 vs 32%). Survivors of childhood ALL often have dental abnormalities that may affect their quality of life. Dental evaluation at diagnosis and frequent followup may help to ensure appropriate preventive measures and minimize dental and periodontal disease.
引用
收藏
页码:792 / 796
页数:5
相关论文
共 50 条
  • [41] Mucoepidermoid carcinoma of parotid gland as a subsequent neoplasm in children treated for acute lymphoblastic leukemia
    Nair, Reghu K. Sukumaran
    Rajeswari, Binitha
    Thankamony, Priyakumari
    Parukuttyamma, Kusumakumary
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (03) : 655
  • [42] Effectiveness of pamidronate as treatment of symptomatic osteonecrosis occurring in children treated for acute lymphoblastic leukemia
    Leblicq, Coralie
    Laverdiere, Caroline
    Decarie, Jean-Claude
    Delisle, Jean-Francois
    Isler, Marc H.
    Moghrabi, Albert
    Chabot, Gilles
    Alos, Nathalie
    PEDIATRIC BLOOD & CANCER, 2013, 60 (05) : 741 - 747
  • [43] Longitudinal growth and risk factors for growth deficiency in children treated for acute lymphoblastic leukemia
    Oliveira Pinto Vilela, Maria Ivone
    Viana, Marcos Borato
    PEDIATRIC BLOOD & CANCER, 2007, 48 (01) : 86 - 92
  • [44] Influence of race and socioeconomic status on outcome of children treated for childhood acute lymphoblastic leukemia
    Bhatia, S
    CURRENT OPINION IN PEDIATRICS, 2004, 16 (01) : 9 - 14
  • [45] Predictive factors of internalized and externalized behavioral problems in children treated for acute lymphoblastic leukemia
    Marcoux, Sophie
    Robaey, Philippe
    Krajinovic, Maja
    Moghrabi, Albert
    Laverdiere, Caroline
    PEDIATRIC BLOOD & CANCER, 2012, 58 (06) : 971 - 977
  • [46] Severe drug-induced hypertriglyceridemia treated with plasmapheresis in children with acute lymphoblastic leukemia
    Zawitkowska, Joanna
    Lejman, Monika
    Zaucha-Praimo, Agnieszka
    Sekula, Natasza
    Greczkowska-Chmiel, Teresa
    Drabko, Katarzyna
    TRANSFUSION AND APHERESIS SCIENCE, 2019, 58 (05) : 634 - 637
  • [47] Desensitization to pegaspargase in children with acute lymphoblastic leukemia and lymphoblastic lymphoma
    August, Keith J.
    Farooki, Sana
    Fulbright, Joy M.
    August, Amanda
    Portnoy, Jay M.
    Pommert, Lauren
    Burke, Michael J.
    Guest, Erin M.
    PEDIATRIC BLOOD & CANCER, 2020, 67 (01)
  • [48] Thrombotic risk in children with acute lymphoblastic leukemia
    Dreyfus, M
    PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2001, 18 (04) : 233 - 234
  • [49] Improved therapy for children with acute lymphoblastic leukemia
    Komada, Y
    Sakurai, M
    BIOMEDICINE & PHARMACOTHERAPY, 1996, 50 (3-4) : 132 - 139
  • [50] GRANULAR ACUTE LYMPHOBLASTIC-LEUKEMIA IN CHILDREN
    INVERNIZZI, R
    ROSANDA, C
    BASSO, G
    CONTER, V
    DICATALDO, A
    FENU, S
    FORNI, M
    FRAPPAMPINA, V
    GRANCHI, D
    LOCATELLI, F
    MIANO, C
    SANTOSTASI, T
    CANTURAJNOLDI, A
    HAEMATOLOGICA, 1992, 77 (01) : 30 - 34